A prospective randomised study comparing two techniques for establishing Continuous Femoral Nerve Blockade for postoperative analgesia following Total Knee Joint Replacement
A prospective randomised study comparing a stimulating catheter (StimuCathTM Continuous Nerve Block Set, Arrow International) and a non-stimulating catheter (ContiplexR Tuohy Continuous Nerve Block Set, B. Braun) for establishing Continuous Femoral Nerve Blockade for postoperative analgesia following Total Knee Joint Replacement
Department of Anaesthesia, St Vincent's Hospital Melbourne
78 participants
May 4, 2005
Interventional
Conditions
Eligibility
Inclusion Criteria1
- Patients undergoing primary Total Knee Joint Replacement.
Exclusion Criteria1
- Previous opioid dependence and/or chronic pain syndrome.Allergy or sensitivity to any study drugs including cycloosygenase inhibitors.BMI > 38 and the inability to palpate landmarks.Inability to comprehend a VAS scale or use of patient controlled analgesia (PCA).Any contraindication to femoral nerve block.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This prospective randomised controlled study has been designed to examine if a stimulating catheter insertion (StimuCathTM Continuous Nerve Block Set, Arrow Internationl) technique improves the quality of Continuous Femoral Nerve Blockade following Total Knee Joint Replacement when compared to non-stimulating catheter insertion (ContiplexR Tuohy Continuous Nerve Block Set, B. Braun). Femoral nerve catheter insitu for no more than 24 hours.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000417684